SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011443
Filing Date
2018-08-13
Accepted
2018-08-13 08:30:20
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 970226
2 ex31-1.htm EX-31.1 16504
3 ex31-2.htm EX-31.2 16331
4 ex32-1.htm EX-32.1 6497
5 ex32-2.htm EX-32.2 6351
  Complete submission text file 0001493152-18-011443.txt   3375928

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pbi-20180630.xml EX-101.INS 447826
7 XBRL SCHEMA FILE pbi-20180630.xsd EX-101.SCH 35942
8 XBRL CALCULATION FILE pbi-20180630_cal.xml EX-101.CAL 36542
9 XBRL DEFINITION FILE pbi-20180630_def.xml EX-101.DEF 178701
10 XBRL LABEL FILE pbi-20180630_lab.xml EX-101.LAB 235226
11 XBRL PRESENTATION FILE pbi-20180630_pre.xml EX-101.PRE 229429
Mailing Address P.O. BOX 666 OLDWICK NJ 08858
Business Address P.O. BOX 666 OLDWICK NJ 08858 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 181010351
SIC: 2834 Pharmaceutical Preparations